Chiratae reaches $93m first close on debut India growth fund
India-based venture capital firm Chiratae Ventures has achieved a first close of INR 7.59bn (USD 93m) on its debut growth fund, announcing that it was substantially oversubscribed.
In February, Sudhir Sethi (pictured), the firm’s founder and chairman told Mergermarket, AVCJ’s sister title, that a target of USD 200m had been set for the growth fund. Chiratae would follow up by...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.